» Articles » PMID: 37354225

Increased Rate of Complications Following Total Knee Arthroplasty in Patients with Systemic Sclerosis

Overview
Journal Int Orthop
Specialty Orthopedics
Date 2023 Jun 24
PMID 37354225
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Outcomes after total knee arthroplasty (TKA) for patients with systemic sclerosis (SSc) are poorly documented in the literature. The purpose of this study was to evaluate SSc as a potential risk factor for increased rate of complications after TKA.

Methods: Using the PearlDiver Mariner database, 2,002 patients with SSc undergoing primary TKA were identified and compared to matched controls of 19,892 patients without SSc. Multivariable logistic regression analyses were done for medical complications up to 90 days and surgical complications up to two years. 90-day ED-visit and inpatient readmission were also documented.

Results: Compared to the matched controls, patients with SSc demonstrated higher rates of medical complications such as cerebrovascular accident (1.5% vs 0.6%, p < 0.001), myocardial infarction (1.3% vs 0.3%, p < 0.001), and sepsis (1.1% vs 0.4%, p < 0.001). Additionally, patients with SSc displayed elevated rates of surgical complications, including wound complications (3.9% vs 2.2%, p < 0.001) and aseptic loosening at 90 days (0.2% vs 0.1%; OR 3.53 [1.13-9.28]), one year (0.7% vs 0.4%; OR 1.78 [0.96-3.05]), and two years (1.4% vs 0.9%; OR 1.68 [1.10-2.45]). Patients with SSc also had higher rates of emergency department visits (21.2% vs 11.4%, p < 0.001).

Conclusions: Patients with SSc are at higher risks of postoperative complications, encompassing both medical and surgical complications. Specifically, patients with SSc have a significantly higher likelihood of experiencing wound complications, cerebrovascular accident, and myocardial infarction. It is crucial for orthopaedic surgeons and patients alike to consider the elevated risks when determining a course of TKA for patients with SSc.

Citing Articles

Impact of systemic lupus erythematosus (SLE) on outcomes following aseptic and septic revision total knee arthroplasty: an analysis of the 2005-2018 nationwide inpatient sample.

Zhao G, Huang X, Shi J, Chen J, Chen F, Wei Y Clin Rheumatol. 2024; 43(10):3127-3137.

PMID: 39136835 DOI: 10.1007/s10067-024-07098-w.

References
1.
Denton C, Khanna D . Systemic sclerosis. Lancet. 2017; 390(10103):1685-1699. DOI: 10.1016/S0140-6736(17)30933-9. View

2.
Asano Y . Systemic sclerosis. J Dermatol. 2017; 45(2):128-138. DOI: 10.1111/1346-8138.14153. View

3.
Gu Y, Kong J, Cheema G, Keen C, Wick G, Gershwin M . The immunobiology of systemic sclerosis. Semin Arthritis Rheum. 2008; 38(2):132-60. DOI: 10.1016/j.semarthrit.2007.10.010. View

4.
Hasan O, Jessar M, Ashar M, Noordin S, Ahmad T . Systemic sclerosis: Clinical manifestations, anesthetic and orthopedic considerations in a patient. Int J Surg Case Rep. 2017; 42:24-28. PMC: 5724744. DOI: 10.1016/j.ijscr.2017.11.051. View

5.
Clements P, Allanore Y, Khanna D, Singh M, Furst D . Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis. Semin Arthritis Rheum. 2011; 41(6):801-14. DOI: 10.1016/j.semarthrit.2011.10.003. View